To investigate the cellular origin of ADA in carcinogenesis, we measured its activity in different types of murine and human cells engaged in tumour development, such as endothelial cells, immune cells (monocytes/macrophages) and breast cancer cells. The gene discussed is ADA; the disease is neoplasm.